Abstract:Striving to identify the molecular targets of a bioactive compound, target deconvolution acts as the link between phenotypic chemical screening and comprehensive exploration of the underlying mechanisms. Various chemoproteomic approaches, facilitated by chemical probe‐assisted target enrichment or probe‐free methodologies, have been developed and employed in target deconvolution. These approaches significantly contribute to elucidating biological mechanisms and advancing drug discovery processes. As a vital project of forward chemical genetic research, target deconvolution aims to identify the molecular targets of an active hit compound. Chemoproteomics, either with chemical probe‐facilitated target enrichment or probe‐free, provides a straightforward and effective approach to profile the target landscape and unravel the mechanisms of action. Canonical methods rely on chemical probes to enable target engagement, enrichment, and identification, whereas click chemistry and photoaffinity labeling techniques improve the efficiency, sensitivity, and spatial accuracy of target recognition. In comparison, recently developed probe‐free methods detect protein‐ligand interactions without the need to modify the ligand molecule. This review provides a comprehensive overview of different approaches and recent advancements for target identification and highlights the significance of chemoproteomics in investigating biological processes and advancing drug discovery processes.

The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery

Chemoproteomics and Chemical Probes for Target Discovery

Chemoproteomics, A Broad Avenue to Target Deconvolution

Exploiting Chemical Probes for Identifying Drug Target Proteins

Hit me with your best shot: Integrated hit discovery for the next generation of drug targets

Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery

Chemoproteomics: Towards Global Drug Target Profiling

PROTAC technology: From drug development to probe technology for target deconvolution

[Chemical Proteomics and Discovery of Drug Targets].

Chemical coverage of human biological pathways

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system

Chemical Coverage of the Human Reactome

Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation

Bridging the gap between target-based and phenotypic-based drug discovery

Recent Advances in Target Identification by Natural Product Based Chemical Probes

Phenotype and Target-Based Chemical Biology Investigations in Cancers

Network pharmacology: the next paradigm in drug discovery

CellEKT: A robust chemical proteomics workflow to profile cellular target engagement of kinase inhibitors

Targeted Molecular Diversity in Drug Discovery: Integration of Structure-Based Design and Combinatorial Chemistry

Multi-Component Reactions in Drug Discovery